• Revenue Cycle Management
  • COVID-19
  • Reimbursement
  • Diabetes Awareness Month
  • Risk Management
  • Patient Retention
  • Staffing
  • Medical Economics® 100th Anniversary
  • Coding and documentation
  • Business of Endocrinology
  • Telehealth
  • Physicians Financial News
  • Cybersecurity
  • Cardiovascular Clinical Consult
  • Locum Tenens, brought to you by LocumLife®
  • Weight Management
  • Business of Women's Health
  • Practice Efficiency
  • Finance and Wealth
  • EHRs
  • Remote Patient Monitoring
  • Sponsored Webinars
  • Medical Technology
  • Billing and collections
  • Acute Pain Management
  • Exclusive Content
  • Value-based Care
  • Business of Pediatrics
  • Concierge Medicine 2.0 by Castle Connolly Private Health Partners
  • Practice Growth
  • Concierge Medicine
  • Business of Cardiology
  • Implementing the Topcon Ocular Telehealth Platform
  • Malpractice
  • Influenza
  • Sexual Health
  • Chronic Conditions
  • Technology
  • Legal and Policy
  • Money
  • Opinion
  • Vaccines
  • Practice Management
  • Patient Relations
  • Careers

Stalking Dividends


The dividend play is back, as beaten-down stock prices have effectively boosted percentage yields.

There was a time when dividend payouts were one of the main attractions to owning stocks and the aim of many investors was to build a portfolio that would provide a steady income stream year after year. Then a succession of bull markets switched the emphasis to price growth until the brutal bear market that came on the scene last Fall. Now, say some market mavens, the dividend play is back, as beaten-down stock prices have effectively boosted percentage yields.

Even though the market is off its recent lows, say these investments gurus, trying to predict that it has hit bottom can be risky. In the meantime, there are several companies in good financial health that are paying dividends of 4% or more, offering the relative safety of a robust balance sheet along with yields that are better than money market funds. Long-term investors may also eventually see significant price appreciation if the bear ever loosens its stranglehold on the stock market.

Among the name companies that are paying dividends in the 4%-6% range are drug makers Astra-Zeneca (5.7%), Bristol-Myers Squibb (5.65%), and Novartis (4.5%). They are joined by food companies like Heinz (4.9%), Kraft (5.0%), and Sysco Corporation (4.0%), along with consumer products giant Kimberly-Clark (4.95%). Experts caution, however, that investors should still do due diligence when buying any stock. Check balance sheets and visit online financial sites to research any potential buys.

Related Videos
Victor J. Dzau, MD, gives expert advice
Victor J. Dzau, MD, gives expert advice